Bio-Connect

Goat anti-PRL1 / PTP4A1 Antibody

EB06456
Everest Biotech
ApplicationsImmunoFluorescence, Western Blot, ELISA
Product group Antibodies
ReactivityCanine, Human, Mouse, Rat
TargetPTP4A1
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-PRL1 / PTP4A1 Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Additional validation: This antibody has been successfully used in the following paper: Achiwa H et al. (2007) PMID: 17234774.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA
  • Applications Supplier
    Pep-ELISA, WB
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID7803
  • Target name
    PTP4A1
  • Target description
    protein tyrosine phosphatase 4A1
  • Target synonyms
    HH72, PRL-1, PRL1, PTP(CAAX1), PTPCAAX1, protein tyrosine phosphatase type IVA 1, PVT1/PTP4A1 fusion, phosphatase of regenerating liver 1, protein tyrosine phosphatase type IVA protein 1, protein tyrosine phosphatase type IVA, member 1, protein-tyrosine phosphatase of regenerating liver 1
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_003454.1. Purification: Antigen affinity purified. Names and symbols: PTP4A1; HH72; PRL1; PRL-1; PTPCAAX1; PTP(CAAX1); protein tyrosine phosphatase type IVA, member 1; Protein tyrosine phosphatase IVA1; RP5-1148A21.2; DKFZp779M0721; protein tyrosine phosphatase type IVA protein 1
  • Reactivity
    Canine, Human, Mouse, Rat
  • Reactivity Supplier
    Human, Mouse, Rat, Dog
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Min SH, Kim DM, Heo YS, et al. New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53. Oncogene. 2009,28(4):545-54. doi: 10.1038/onc.2008.409
    Read this paper
  • Achiwa H, Lazo JS. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res. 2007,67(2):643-50.
    Read this paper